With regards to yeast infections, nearly all women will likely need to face this infection at least once in their lives. Prescription medications and harmful home remedies have always been the methods that women have used to take care of these issues. A few of you may have possibly tried boric acid as one of the home remedies which is extremely dangerous and has even caused death. Yeast infections are additionally not limited to women as a large number of men have also needed to deal with this. In this post we will be going over the 12 Hour Yeast Infection Cure.
This program doesn’t use harmful drugs to take care of your yeast infections, rather it is an all natural way to cure them. You need to recognize that many of the drugs on the market for yeast infections can actually end up leading to more harmful issues within your body. Something else you should know is the fact that drug companies don’t want you to learn about this all natural cure simply because they can not earn money from it. This also comes down to a legal concern, as all the drug companies are mandated by law to provide a profit for all of their share holders. However there is actually no law on record that says that these drug companies must generate drugs that help people.
This is something else that may surprise you, many women suffer from yeast infections but never know it. You are able to go to the 12 Hour Yeast Infection Cures site and see a list of symptoms that might be from yeast infections. You will sometimes find that when people go to the doctors for some of these symptoms they’re commonly mistaken for other conditions. Like I said you can see the list of symptoms on their site, and you do not have to purchase anything to have a look.
Something else you will discover with this program is how to treat the root cause of your yeast infection. More than likely many of you have used the prescription medications and found that a month or so later your yeast infection is back, this is because these medicines only tackle the symptoms and not the cause. Which explains why this program is so powerful, you will be treating both the symptoms and the root cause of the infection.
Also on their website I was amazed to find so many testimonials from people who have used this program and remedied their yeast infections fast. And while this shouldn’t have amazed me but it did, is the fact that through out these testimonials you will even find some from men. These testimonials are all coming from individuals who have used this program and cured themselves of their particular yeast infections, which in my opinion, is rather amazing.
The product itself is selling for $29.95 and when you think about all the money you would spend on the medications you could wind up saving a lot of money over time. They have also incorporated a 60 day cash back refund, so if you use the program and your not happy with it for any reason you can just ask for a refund. When people add that kind of guarantee to a product you already know that they have complete faith in the results people will acquire from it.
Main Category: Hypertension
Also Included In: GastroIntestinal / Gastroenterology; Immune System / Vaccines; Radiology / Nuclear Medicine
Article Date: 21 Jun 2011 – 5:00 PDT
email to a friend printer friendly opinions
<!– rate article
Patient / Public:
Healthcare Prof:
1. For Hypertension Patients, Single Reading Not Enough to Assess Blood Pressure Control
Using Multiple Readings Increases Measurement Accuracy
For patients with hypertension, physicians typically use a single in-office blood pressure (BP) reading to assess how well medical interventions are working and then adjust hypertension medications accordingly. However, some patients may experience a phenomenon known as “white coat” hypertension, meaning they have a higher than normal BP due to the anxiety associated with the office visit. Researchers sought to determine how many readings would be needed to accurately determine whether a patient’s BP was under control. They followed 444 veterans with hypertension for 18 months to compare three different strategies for BP measurement: standardized research BP measurement every six months; in-office BP measurements taken during outpatient visits; and home BP measurements using a monitor that transmitted results electronically. The researchers found that taking an average BP reading from several measurements resulted in substantially greater accuracy in diagnosis. The authors recommend that home monitoring could improve the quality of blood pressure care.
2. Experts Recommend Multidetector Computed Tomography as Standard Preoperative Care for Suspected Appendicitis
Acute appendicitis can be difficult to diagnose, as the symptoms of appendicitis mirror those of other illnesses. Accurate diagnosis is important because patients with appendicitis go to surgery, while those that do not have appendicitis do not. Computed tomography is often used to help diagnose appendicitis, but high quality studies of its effectiveness in this situation have been lacking. Researchers reviewed hospital records for 2,871 adult patients with suspected appendicitis between 2000 and 2009 to determine if multidetector computed tomography (MDCT) could accurately rule in or rule out appendicitis. The researchers found that MDCT was sensitive and specific enough to identify the approximately one quarter of patients with actual appendicitis who needed urgent surgery, and it identified a probable alternative cause of symptoms in those who did not have appendicitis. In addition, preoperative MDCT can reduce rates of perforation and negative findings at appendectomy. The researchers recommend MDCT as the standard of care for suspected appendicitis in adults.
3. Insufficient Evidence to Support Preemptive Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines
Thiopurine-based drugs are sometimes used to treat patients with chronic inflammatory autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. Because thiopurine-based drugs can lead to severe lowering of blood counts in patients with reduced or absent thioputine S-methyltransferase (TPMT) enzyme, some experts recommend routine measurement of TPMT activity before prescribing these drugs. Another approach is to start the drugs, monitor blood counts, and stopping the drug if blood counts fall. Researchers reviewed 55 published studies to examine the sensitivity and specificity of TPMT genotyping for several purposes: measuring TPMT enzymatic activity; reducing harm from thiopurine; and to determine the association of thiopurine toxicity with TPMT status in adults and children with chronic inflammatory diseases. The researchers found insufficient evidence that TPMT pretesting guides appropriate prescribing or improves patient outcomes (such as by limiting toxicity) compared with routine blood count monitoring in patients receiving thiopurine therapy. The authors of this study and the author of an accompanying editorial call for more research about biological testing to preempt prescribing mediations with potentially harsh side-effects in particular patients.
Source:
Angela collom
American College of Physicians
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.
Follow us on Twitter Hypertension headlines email to a friend printer friendly version weekly newsletter personalize your news
Main Category: Colorectal Cancer
Also Included In: Genetics; Clinical Trials / Drug Trials; GastroIntestinal / Gastroenterology
Article Date: 19 Jun 2011 – 2:00 PDT
email to a friend printer friendly opinions
<!– rate article
Patient / Public:
5 (1 votes)
Healthcare Prof:
5 (2 votes)
A compound that for about 60 years has been used as a drug against tapeworm infection is also apparently effective against colon cancer metastasis, as studies using mice have now shown. The compound silences a gene that triggers the formation of metastases in colon cancer. Professor Ulrike Stein (Experimental and Clinical Research Center, a joint cooperation between the Charite Medical Faculty and the Max Delbrück Center for Molecular Medicine, (MDC)) and her research group made this discovery in collaboration with Professor Robert H. Shoemaker of the National Cancer Institute (NCI) in Frederick, Maryland, USA (Journal of the National Cancer Institute, Vol. 103, No. 12, June 17, 2011)*. Plans are already underway with Professor Peter M. Schlag (Charite Comprehensive Cancer Center) to conduct a clinical trial.
Colon cancer is one of the most common tumor diseases in Western countries. In Germany alone, there are approximated 73 000 new cases of the disease every year. Despite surgery, chemotherapy and radiation therapy, only about half of the affected patients are cured.
The reason is that around 20 percent of the colon cancer patients already have metastases at diagnosis and in about one third of the patients, metastasis occurs despite successful initial treatment. Of these patients with metastatic colon cancer, the five-year survival rate is only about 10 percent. By contrast, for nonmetastatic colon cancer patients the survival rate is 90 percent.
Scientists have known for several years that the gene S100A4/metastasin can initiate colon cancer metastasis. Five years ago Professor Stein, working together with Professor Schlag and Professor Walter Birchmeier (MDC), showed how this gene is regulated. They found that the beta-catenin gene, when mutant, activates this S100A4/metastasin gene, thus triggering colon cancer metastasis. Beta-catenin normally regulates cellular adhesion.
The scientists looked for compounds that block the expression of the metastasin gene. They screened 1280 compounds and found what they were looking for: niclosamide, a drug until now approved for use to treat intestinal parasite infections from tapeworms.
Surprisingly, the researchers discovered that niclosamide inhibits the beta catenin-driven expression of the S100A4/metastasin gene, both in the cell culture and in mice. The animals had fewer metastases. Next, the researchers want to conduct clinical trials to find out whether the compound is also effective in patients with metastasizing colon cancer.
*Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer Ulrike Sack, Wolfgang Walther, Dominic Scuiero, Mike Selby, Dennis Kobelt, Margit Lemm, Iduna Fichtner, Peter M. Schlag, Robert H. Shoemaker, Ulrike Stein.
Source:
Barbara Bachtler
Helmholtz Association of German Research Centres
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.
Follow us on Twitter Colorectal Cancer headlines email to a friend printer friendly version weekly newsletter personalize your news
email to a friend 
printer friendly 
opinions 
rate article
Hypertension headlines
weekly newsletter
personalize your news
email to a friend 
printer friendly 
opinions 
rate article
Colorectal Cancer headlines
weekly newsletter
personalize your news